犬の血管肉腫における塩酸ドキソルビシンの治験例

• Published in: Journal of Animal Clinical Medicine Vol. 26; no. 3; pp. 136 - 138
• Main Authors: 山本, 成美, 渋谷, 久, 鈴木, 隆, 佐藤, 常男, 山田, 裕一, 勝呂, 篤志
• Format: Journal Article
• Language: Japanese
• Published: 動物臨床医学会 25.09.2017; Japanese Society of Clinical Veterinary Medicine
• Subjects: canine; chemotherapy; hemangiosarcoma; 化学療法; 犬; 血管肉腫
• ISSN: 1344-6991; 1881-1574
• DOI: 10.11252/dobutsurinshoigaku.26.136

Six dogs that were diagnosed with hemangiosarcoma were treated by surgery only (3 dogs) and or by administration of doxorubicin after the surgery (3 dogs). The mean survival days for each treatment were 87 days and 189 days, respectively. Thus, the mean survival days for cases that received the latter treatment was 102 days longer than that for cases that received the former treatment. 血管肉腫の犬6症例に対して外科手術単独の症例と，外科手術後に塩酸ドキソルビシンによる化学療法を併用した症例での生存日数を比較した。外科手術単独3症例での平均生存日数は87日，外科手術後に塩酸ドキソルビシンの化学療法を実施した3症例の平均生存日数は189日であった。化学療法を実施した症例の平均生存日数は，外科手術単独症例に比べ102日長かった。